推荐产品
等级
pharmaceutical primary standard
API类
octinoxate
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
包装形式
neat
SMILES字符串
CCCCC(CC)COC(=O)\C=C\c1ccc(OC)cc1
InChI
1S/C18H26O3/c1-4-6-7-15(5-2)14-21-18(19)13-10-16-8-11-17(20-3)12-9-16/h8-13,15H,4-7,14H2,1-3H3/b13-10+
InChI key
YBGZDTIWKVFICR-JLHYYAGUSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Octinoxate USP reference standard suitable for use in specified USP compendial quality tests and assays.
Also used to prepare standard and system suitability solution during the assay of Octinoxate by using gas chromatography in conjunction with flame ionization detector.
Also used to prepare standard and system suitability solution during the assay of Octinoxate by using gas chromatography in conjunction with flame ionization detector.
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
危险声明
预防措施声明
危险分类
Aquatic Chronic 4
储存分类代码
10 - Combustible liquids
WGK
WGK 2
闪点(°F)
379.4 °F
闪点(°C)
193 °C
Octinoxate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(3), 3225-3225 (2020)
Timothy P Murphy et al.
Journal of the American College of Cardiology, 65(10), 999-1009 (2015-03-15)
Treatment for claudication that is due to aortoiliac peripheral artery disease (PAD) often relies on stent revascularization (ST). However, supervised exercise (SE) is known to provide comparable short-term (6-month) improvements in functional status and quality of life. Longer-term outcomes are
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门